Olive Lifesciences Pvt Ltd   Report issue

For profit Phase 3
Founded: Bangalore India (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2012
NCT01680211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Metabolic Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 7